Pharmaceutical Companies
Rafael Holdings
πΊπΈUnited States
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the Healthcare and Real Estate segments. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and...
AEON Biopharma
πΊπΈUnited States
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on...
Curis, Inc.
πΊπΈUnited States
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 49
- Market Cap
- $35.9M
- Website
- http://www.curis.com
Cue Biopharma, Inc
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $35.4M
- Website
- -
AN2 Therapeutics
πΊπΈUnited States
- Ownership
- Public
- Established
- 2017-01-01
- Employees
- 41
- Market Cap
- $34.9M
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was...
Incannex Healthcare
π¦πΊAustralia
- Ownership
- -
- Established
- -
- Employees
- 10
- Market Cap
- $34.7M
- Website
- -
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine...
Lianbio
πΊπΈUnited States
Medigene AG
π©πͺGermany
Tempest Therapeutics
πΊπΈUnited States
Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.
Atara Biotherapeutics
πΊπΈUnited States
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune...